| | January 202119CIOReviewCIOReviewArtios Pharmaartiospharma.comA leading independent DNA Damage Response company with a strong pipeline of novel cancer therapies in development with first-in-class potentialADC Biotechnologyadcbio.comAn innovative biotechnology company specialising in Antibody Drug ConjugatesMGB Biopharmamgb-biopharma.comManufacturing speciality drugs targeting smaller patient populations lower volume batches per productAstraZenecaastrazeneca.comA global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwideBiopharm Servicesbiopharmservices.comEnables biopharma innovators to reduce manufacturing costs and make informed process decisions to improve profitability and ultimately patient accessHealxhealx.ioMakes drug discovery faster, smarter and safer, and supports team and partners in discovering and translating new treatments towards the clinicHorizon Discovery horizondiscovery.comOutsource cell line engineering or screening projects with Horizon's experienced contract research service teamsNodThera nodthera.comPowerful drug discovery platform built on next-generation NLRP3 inflammasome chemistryKymabkymab.comThe company's unique technologies drive the rapid development of effective, human antibody-based drugs across our four main therapeutic areas - immuno-oncology, inflammation, haematology and infectious diseaseAdaptimmune adaptimmune.comBuilds affinity-enhanced T-cell therapies aimed at destroying cancer cellsCOMPANYD ES CR I P T I O N
< Page 9 | Page 11 >